Shari Kaiser
Overview
Explore the profile of Shari Kaiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
1326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waldschmidt J, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, et al.
Blood Adv
. 2025 Jan;
9(5):1132-1136.
PMID: 39813623
No abstract available.
2.
Holstein S, Asimakopoulos F, Azab A, Bianchi G, Bhutani M, Crews L, et al.
Transplant Cell Ther
. 2022 May;
28(8):446-454.
PMID: 35605882
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included...
3.
Munshi N, Anderson Jr L, Shah N, Madduri D, Berdeja J, Lonial S, et al.
N Engl J Med
. 2021 Feb;
384(8):705-716.
PMID: 33626253
Background: Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigen-directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expected CAR T-cell toxic effects in patients with...
4.
Da Via M, Dietrich O, Truger M, Arampatzi P, Duell J, Heidemeier A, et al.
Nat Med
. 2021 Feb;
27(4):616-619.
PMID: 33619368
B cell maturation antigen (BCMA) is a target for various immunotherapies and a biomarker for tumor load in multiple myeloma (MM). We report a case of irreversible BCMA loss in...
5.
Samur M, Fulciniti M, Aktas Samur A, Bazarbachi A, Tai Y, Prabhala R, et al.
Nat Commun
. 2021 Feb;
12(1):868.
PMID: 33558511
BCMA targeting chimeric antigen receptor (CAR) T cell therapy has shown deep and durable responses in multiple myeloma. However, relapse following therapy is frequently observed, and mechanisms of resistance remain...
6.
Pattabhi S, Wilkins C, Dong R, Knoll M, Posakony J, Kaiser S, et al.
J Virol
. 2015 Dec;
90(5):2372-87.
PMID: 26676770
Unlabelled: The cellular response to virus infection is initiated when pathogen recognition receptors (PRR) engage viral pathogen-associated molecular patterns (PAMPs). This process results in induction of downstream signaling pathways that...
7.
Aderem A, Adkins J, Ansong C, Galagan J, Kaiser S, Korth M, et al.
mBio
. 2011 Feb;
2(1):e00325-10.
PMID: 21285433
The twentieth century was marked by extraordinary advances in our understanding of microbes and infectious disease, but pandemics remain, food and waterborne illnesses are frequent, multidrug-resistant microbes are on the...